CRYSTAL SHEN: Open Payments
NPI 1336858323 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 11 payments from 8 companies in 2025. Trend: 2023 $251 · 2024 $844 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $113 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 1 | $29 |
| ABBVIE INC. | 1 | $21 |
| Phadia US Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: REPATHA, MOUNJARO, PREVNAR 20, UBRELVY, EVENITY, ImmunoCAP, Saxenda, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
